In the BioHarmony Drug Report Database

"Preview" Icon

Phenylbutazone

Butazolidin (phenylbutazone) is a small molecule pharmaceutical. Phenylbutazone was first approved as Butazolidin on 1982-01-01. It is used to treat gouty arthritis in the USA. The pharmaceutical is active against prostaglandin G/H synthase 1 and prostaglandin G/H synthase 2. In addition, it is known to target albumin.

 

Trade Name

 

Butazolidin
 

Common Name

 

phenylbutazone
 

ChEMBL ID

 

CHEMBL101
 

Indication

 

gouty arthritis
 

Drug Class

 

Anti-inflammatory analgesics (phenylbutazone type)

Image (chem structure or protein)

Phenylbutazone structure rendering